Prostate Cancer | Tumor

The Incredible Shrinking Patient With Cancer

August 2nd 2022

Cancer treatment-related osteoporosis caused me to shrink two inches.

Easy-to-Swallow Drug Being Investigated for Prostate Cancer Treatment

August 1st 2022

TAVT-45, an easy-to-swallow drug that can be suspended in water or juice, is being studied for the treatment of patients with metastatic prostate cancer.

Treatment Journey Shared by a Patient with mCRPC and his Caregiver

July 26th 2022

Joseph Wood details his treatment journey with metastatic castration-resistant prostate cancer (mCRPC) and how the journey has impacted his wife and caregiver, Deborah Wood.

VISION Trial of Lutetium-177-PSMA-617 in mCRPC: Clinical Implications

July 26th 2022

Dr Jeremie Calais reviews the VISION trial and the implications of the data in the treatment paradigm for metastatic castration-resistant prostate cancer (mCRPC).

I’ve Found a New Home With Other Cancer Survivors

July 19th 2022

As I reflect on cancer survivorship, I notice how important the camraderie with fellow survivors is.

Emergence of PSMA Targeted Radioligand Therapy

July 13th 2022

Dr Jeremie Calais talks about the emergence and importance of PSMA-targeted radioligand therapy.

Front-Line Treatment Options for Patients with mCRPC

July 13th 2022

Dr Matthew Rettig reviews the front-line treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC) and what factors are considered when choosing appropriate treatment.

When Dealing With Cancer, Don’t Treat Your Spouse Like a Therapist

July 5th 2022

While my wife has been an amazing caregiver throughout my cancer experience, I realized that it was not fair for her to continually be on the receiving end of all my negative emotions.

mCRPC Diagnosis: The Patient and Caregiver Experience

July 1st 2022

Joseph Wood, a patient, and Deborah Wood, Joseph’s wife and caregiver, talk about Joseph’s prostate cancer diagnosis and Deborah explains her role as a caregiver.

Importance and the Process of PSMA PET Imaging in mCRPC

July 1st 2022

Jeremie Calais, MD, comments on how PSMA PET scans have changed the treatment landscape for patients with mCRPC and describes the process for obtaining a PSMA PET scan, including what patients should know before, during and after the scan.

5 FDA Cancer Drug Approvals for Solid Tumors That Patients May Have Missed

June 29th 2022

Here is a roundup of cancer treatments that were approved by the FDA in the spring of 2022 that patients may have missed.

Sharing a Cancer Diagnosis with Family, in Verse

June 21st 2022

Looking back, perhaps a poem could have helped me tell my family about my cancer diagnosis.

Educated Patient® Prostate Cancer Summit Looking Ahead Panel: May 21, 2022

June 17th 2022

Watch Dr. Jeremie Calais, Dr. Tian Zhang, Dr. Landon C. Brown and Jim Rosenfield answer questions about novel agents and strategies during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Approaches to Hormone Therapy Presentation: May 21, 2022

June 16th 2022

Watch Dr. Landon C. Brown, from Atrium Health Levine Cancer Institute, discuss approaches to hormone therapy, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Novel Agents Presentation: May 21, 2022

June 15th 2022

Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Novel Imaging Strategies Presentation: May 21, 2022

June 14th 2022

Watch Dr. Jeremie Calais, from UCLA, discuss novel imaging strategies, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genetics & Genomics Panel: May 21, 2022

June 13th 2022

Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genomics Presentation: May 21, 2022

June 12th 2022

Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genetic Testing Presentation: May 21, 2022

June 11th 2022

Watch Dr. Veda N. Giri, from Sidney Kimmel Cancer Center at Thomas Jefferson University, discuss genetic testing and who should get it, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Treatment in Localized Disease Panel: May 21, 2022

June 10th 2022

Watch Dr. Ganesh Raj, Dr. Andrew Z. Wang, and Bruce Williams, discuss treatment for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Approaches to Radiation Presentation: May 21, 2022

June 9th 2022

Watch Dr. Andrew Z. Wang, from UT Southwestern Medical Center, discuss approaches to radiation for local disease, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Overview of Surgery Presentation: May 21, 2022

June 8th 2022

Watch Dr. Ganesh V. Raj, from UT Southwestern Medical Center, discuss surgery for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

Actress Alicia Witt Discusses Cancer Treatment After Losing Her Parents, Chef Gordon Ramsay Surprises a Teen With Cancer and More

June 3rd 2022

From chef Gordon Ramsay sharing a meal with a 13-year-old fan with Ewing sarcoma, to a dermatologist on a playground spotting a mother’s skin cancer, here’s a look at what’s happening in the cancer space this week.

Overview of Metastatic Castration Resistant Prostate Cancer (mCRPC)

June 1st 2022

An overview of metastatic castration-resistant prostate cancer (mCRPC) and the role of PSMA in mCRPC.

Targeted therapy improves outcomes for some metastatic prostate cancer

May 31st 2022

Certain Latino and Hispanic Men More Likely to Be Diagnosed With High-Risk Prostate Cancer

May 19th 2022

Despite Latino and Hispanic men being more likely to present with higher-risk prostate cancer, they are less likely to receive treatment for their disease compared to other ethnicities.

Cancer Creates Empathy, But Hope Must Prevail

May 16th 2022

After experiencing cancer, I feel a profound sense of empathy for others in tough situations, from the war in Ukraine to COVID-19.

Zytiga-Containing Regimen Boosts Survival in Certain Patients With Prostate Cancer

May 6th 2022

Treatment with androgen deprivation therapy in combination with Zytiga, docetaxel and prednisone improved radiographic progression-free survival and overall survival in patients with de novo metastatic castration-sensitive prostate cancer.

FDA Expedites Review of Nubeqa Combination for Metastatic, Hormone-Sensitive Prostate Cancer

May 3rd 2022

Results from a phase 3 trial showed that the combination of Nubeqa, docetaxel and androgen-deprivation therapy significantly decreased the risk of death for men with a certain type of prostate cancer.

Older Patients With Prostate Cancer at a Higher Risk for Heart Complications After Androgen-Deprivation Therapy

May 3rd 2022

While a higher risk of heart issues was found in older men years after androgen-deprivation therapy, it is unknown if the risk comes from the treatment or other age-related comorbidities.